Skip to:


Human IFN-γ ELISpot PRO (HRP), strips

  • Human IFN-γ ELISpot (HRP), strips
  • Human IFN-γ ELISpot (HRP), strips
  • Human IFN-γ ELISpot (HRP), strips
  • Human IFN-γ ELISpot (HRP), strips

ELISpotPRO kit with strip plates for enumeration of cells secreting IFN-γ

The ELISpotPRO kit is Mabtech's most innovative product featuring pre-coated plates and one-step detection. The kit enables enumeration of cells secreting human IFN-γ and contains ELISpot 8-well strip-plates pre-coated with monoclonal antibody, HRP-conjugated antibody for one-step detection and TMB substrate. A polyclonal activator for human T cells (mAb CD3-2) is supplied as a positive control for cytokine secretion.

Pre-coated plates and one-step detection enable a more rapid assay with minimized variability. In addition, strip plates are ideal when running a limited number of wells.

  • ELISpot
  • Human
Documentation: Product datasheet

Product SDS
  • Enzyme-conjugated detection mAb (7-B6-1-HRP)
  • Positive control (anti-CD3 mAb)
  • Substrate (TMB)
  • 2 Pre-coated clear strip plates (mAb 1-D1K)
Size: 2 plates
Other formats: Click to view all Human IFN-γ products
  • Assay principle

    The ELISpot assay explained step-by-step
  • Image gallery

    A library of representative ELISpot and FluoroSpot results.
  • Analyte information

    • IFN-γ
      Interferon-γ (IFN-γ, also known as IFN-gamma, IFN-g, IFNg and Interferon-gamma) is produced mainly by activated T cells and NK cells. It is a proinflammatory cytokine that activates macrophages and endothelial cells, but it also regulates immune responses by effecting APC and T and B cells. Production of IFN-γ by helper T cells as well as cytotoxic T cells is a hallmark of the TH1-type phenotype, thus, high-level production of IFN-γ is typically associated with effective host defense against intracellular pathogens.
  • Ordering information

    Orders to Mabtech can be placed online, by email, or by phone/fax to any of our offices.
  • Find out more

    Visit our Knowledge Center or see the FAQs.